ArticleWorld journal of surgical oncology2024

Efficacy and safety of maintenance therapy with anlotinib for advanced cholangiocarcinoma after first-line chemotherapy and the variations in efficacy based on different neutrophil-to-lymphocyte ratio (NLR).

Hui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.